EXAS - EXACT SCIENCES CORP

QQQ $ 587.32 $ -0.16 (-0.03 %)

DIA $ 459.43 $ -0.15 (-0.03 %)

SPY $ 654.83 $ -0.55 (-0.08 %)

TLT $ 89.48 $ -0.17 (-0.19 %)

GLD $ 373.76 $ -0.24 (-0.07 %)

Previous Close

$ 100.67

Open

$ 100.93

Bid

$ 100.97 x 134

Ask

$ 100.99 x 47

Day's Range

$ 100.81 - $ 101.01

52 Week Range

$ 38.81 - $ 101.87

Volume

67,812,161

Average Volume

Market Cap

19.07B

Beta (5Y Monthly)

$ 1.29

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-03-2025	09-30-2025	10-Q
2	08-06-2025	06-30-2025	10-Q
3	05-01-2025	03-31-2025	10-Q
4	02-19-2025	12-31-2024	10-K
5	11-05-2024	09-30-2024	10-Q
6	07-31-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	02-21-2024	12-31-2023	10-K
9	11-01-2023	09-30-2023	10-Q
10	08-01-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	02-21-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-02-2022	06-30-2022	10-Q
15	04-26-2022	03-31-2022	10-Q
16	02-22-2022	12-31-2021	10-K
17	11-02-2021	09-30-2021	10-Q
18	07-28-2021	06-30-2021	10-Q
19	05-04-2021	03-31-2021	10-Q
20	02-16-2021	12-31-2020	10-K
21	10-27-2020	09-30-2020	10-Q
22	07-31-2020	06-30-2020	10-Q
23	05-06-2020	03-31-2020	10-Q
24	02-21-2020	12-31-2019	10-K
25	10-30-2019	09-30-2019	10-Q
26	07-30-2019	06-30-2019	10-Q
27	04-30-2019	03-31-2019	10-Q
28	02-21-2019	12-31-2018	10-K
29	10-30-2018	09-30-2018	10-Q
30	08-01-2018	06-30-2018	10-Q
31	04-26-2018	03-31-2018	10-Q
32	02-22-2018	12-31-2017	10-K
33	10-30-2017	09-30-2017	10-Q
34	07-25-2017	06-30-2017	10-Q
35	04-27-2017	03-31-2017	10-Q
36	02-21-2017	12-31-2016	10-K
37	10-26-2016	09-30-2016	10-Q
38	07-26-2016	06-30-2016	10-Q
39	05-03-2016	03-31-2016	10-Q
40	02-24-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guggenheim Downgrades Exact Sciences to Ne...
11/21/2025 14:08:29

Guggenheim analyst Subbu Nambi downgrades Exact Sciences (NASDAQ:EXAS) from Buy to Neutral.

Barclays Downgrades Exact Sciences to Equa...
11/21/2025 13:39:14

Barclays analyst Luke Sergott downgrades Exact Sciences (NASDAQ:EXAS) from Overweight to Equal-Weight and raises the price t...

tech-stocks-fall-despite-nvidias-beat-walmart-jumps-6-whats-moving-markets-thursday

Tech Stocks Fall Despite Nvidia's Beat, Wa...
11/20/2025 17:43:19

Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lif...

nutex-health-posts-strong-q3-results-joins-pacs-group-walmart-cerence-and-other-big-stocks-moving-higher-on-thursday

Nutex Health Posts Strong Q3 Results, Join...
11/20/2025 16:36:00

abbotts-21-billion-exact-sciences-buyout-reshapes-cancer-diagnostics

Abbott's $21 Billion Exact Sciences Buyout...
11/20/2025 14:37:44

Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highli...

CORRECTION: Exact Sciences Ticker Is 'EXAS'
11/20/2025 12:44:34

Abbott Signs Agreement To Acquire Exact Sc...
11/20/2025 12:31:56

Abbott (NYSE:ABT) and Exact Sciences (NASDAQ:EXAS) today announced a definitive agreement for Abbott to acquire Exact Sciences,...

Exact Sciences Shares Resume Trade
11/19/2025 18:48:29

UPDATE: 'Abbott Weighs Takeover of Cancer ...
11/19/2025 18:41:40

https://www.bloomberg.com/news/articles/2025-11-19/abbott-weighs-takeover-of-cancer-test-maker-exact-sciences

Exact Sciences Shares Halted On Circuit Br...
11/19/2025 18:39:22

Piper Sandler Maintains Overweight on Exac...
11/11/2025 17:01:37

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target ...

Exact Sciences Announces Expiration HSR Wa...
11/10/2025 12:10:06

Exact Sciences Releases Validation Result...
11/07/2025 13:06:30

Oncoguard® Liver blood test delivers seven times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus...

Wells Fargo Maintains Overweight on Exact ...
11/05/2025 15:19:29

Wells Fargo analyst Brandon Couillard maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target f...

TD Cowen Maintains Buy on Exact Sciences, ...
11/04/2025 18:44:55

TD Cowen analyst Dan Brennan maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $74 to $90.

TD Cowen Maintains Buy on Exact Sciences, ...
11/04/2025 18:44:55

TD Cowen analyst Dan Brennan maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $74 to $90.

palantir-weighs-on-wall-street-bitcoin-slumps-5-whats-moving-markets-tuesday

Palantir Weighs On Wall Street, Bitcoin Sl...
11/04/2025 18:22:32

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, o...

Baird Maintains Outperform on Exact Scienc...
11/04/2025 17:21:04

Baird analyst Catherine Schulte maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $7...

Benchmark Maintains Buy on Exact Sciences,...
11/04/2025 16:14:19

Benchmark analyst Bruce D. Jackson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $60 to...

Guggenheim Maintains Buy on Exact Sciences...
11/04/2025 15:38:14

Guggenheim analyst Subbu Nambi maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $70 to $75.